QVOKLY

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark QVOKLY was filed as Word mark on 06/18/2020 at the World Intellectual Property Organization.

Trademark Details Last update: April 4, 2022

Trademark form Word mark
File reference 1554688
Register number VR202000773
Countries Australia Switzerland China Japan South Korea Norway New Zealand
Base trademark DK No. VR 2020 00773, April 12, 2020
Application date June 18, 2020
Expiration date June 18, 2030

Trademark owner

c/o Ascendis Pharma A/S,
Tuborg Boulevard 5
DK

Trademark representatives

Vejlsøvej 51 8600 Silkeborg DK

goods and services

05 Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer and infectious diseases
09 Computer software and computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, software applications and mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, software applications and mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, software applications and mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps between injection pens and pumps and portable electronic devices; computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history'; the foregoing related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases
10 Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dosage of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for diagnostic purposes namely dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and in a clinic; dosage management dispensers for medicines incorporating software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Trademark history

Date Document number Area Entry
March 31, 2022 2022/13 Gaz JP RAW: Rule 18ter(2)(i) GP following a provisional refusal
January 25, 2022 2022/4 Gaz KR Rejection
December 1, 2021 2022/2 Gaz RAW: Limitation
September 16, 2021 2021/37 Gaz JP Rejection
September 3, 2021 2021/35 Gaz NO Rejection
August 26, 2021 2021/35 Gaz CH Rejection
May 27, 2021 2021/21 Gaz NZ Rejection
February 8, 2021 2021/6 Gaz CN Rejection
January 26, 2021 2021/4 Gaz AU Rejection
June 18, 2020 2020/39 Gaz DK Registration

ID: 141554688